Skip to main content

Advertisement

Log in

Early vascular healing after titanium–nitride–oxide-coated stent versus platinum–chromium everolimus-eluting stent implantation in patients with acute coronary syndrome

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Data on early vascular healing response of novel stent designs are scarce. In this randomized prospective trial, we sought to compare early neointimal coverage of cobalt–chromium-based titanium–nitride–oxide-coated bioactive stents (CoCr-BAS) versus platinum–chromium everolimus-eluting stents (PtCr-EES) at 2-month follow-up in patients with acute coronary syndrome (ACS). Forty patients with ACS were randomized to receive either CoCr-BAS (n = 19) or PtCr-EES (n = 21). Neointimal strut coverage and strut apposition were examined by optical coherence tomography; and coronary flow reserve (CFR), fractional flow reserve (FFR) and index of microcirculatory resistance (IMR) were assessed using a coronary pressure wire at 2 months. Two patients in the PtCr-EES underwent OCT out of the time frame of the study, and were excluded from analysis. At 63 ± 8 days, 302 cross-sections (3412 struts) were analysed in the CoCr-BAS group, and 324 cross-sections (3460 struts) in the PtCr-EES group. Median [IQR] neointimal thickness was 203 [108] µm and 42.2 [41] µm for CoCr-BAS and PtCr-EES, respectively (p < 0.001). Median [IQR] percentage of uncovered struts was 1.2 [2.8] % versus 11.3 [17.7] %, respectively (p < 0.001). Flow measurements were comparable between the two groups (p > 0.05 for all). CoCr-BAS showed earlier and more adequate neointimal coverage of struts at 2 months, compared with PtCr-EES, but with more neointimal hyperplasia. Functional healing as assessed by CFR, FFR, and IMR was similar between the two stent arms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Palmerini T, Biondi-Zoccai G, Riva DDD, Stettler C, Sangiorgi D, D’Ascenzo F, Kimura T, Briguori C, Sabatè M, Kim H-S, De Waha A, Kedhi E, Smits PC, Kaiser C, Sardella G et al (2012) Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. Lancet 379(9824):1393–1402

    Article  CAS  PubMed  Google Scholar 

  2. Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J (2012) Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 125(23):2873–2891

    Article  CAS  PubMed  Google Scholar 

  3. Sarno G, Lagerqvist B, Fröbert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S (2012) Lower risk of stent thrombosis and restenosis with unrestricted use of “new-generation” drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 33(5):606–613

    Article  PubMed  Google Scholar 

  4. Sabaté M, Brugaletta S, Cequier A, Iñiguez A, Serra A, Hernádez-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Backx B, Serruys PW (2014) The EXAMINATION trial (everolimus-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction): 2-year results from a multicenter randomized controlled trial. JACC Cardiovasc Interv 7(1):64–71

    Article  PubMed  Google Scholar 

  5. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115(18):2435–2441

    Article  PubMed  Google Scholar 

  6. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193–202

    Article  PubMed  Google Scholar 

  7. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118(11):1138–1145

    Article  PubMed  Google Scholar 

  8. Mosseri M, Tamari I, Plich M, Hasin Y, Brizines M, Frimerman A, Miller H, Jafari J, Guetta V, Solomon M, Lotan C (2005) Short- and long-term outcomes of the titanium–NO stent registry. Cardiovasc Revasc Med 6(1):2–6

    Article  PubMed  Google Scholar 

  9. Karjalainen PP, Ylitalo A, Airaksinen JK, Nammas W (2011) Five-year clinical outcome of titanium–nitride–oxide-coated bioactive stent implantation in a real-world population: a comparison with paclitaxel-eluting stents: the PORI registry. J Interv Cardiol 24(1):1–8

    Article  PubMed  Google Scholar 

  10. Tuomainen PO, Ylitalo A, Niemelä M, Kervinen K, Pietilä M, Sia J, Nyman K, Nammas W, Airaksinen KEJ, Karjalainen PP (2013) Five-year clinical outcome of titanium–nitride–oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial. Int J Cardiol 168(2):1214–1219

    Article  PubMed  Google Scholar 

  11. Karjalainen PP, Niemela M, Airaksinen JKE, Rivero-Crespo F, Romppanen H, Sia J, Lalmand J, de Bruyne B, De Belder A, Carlier M, Nammas W, Ylitalo A, Hess OM (2012) A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial. EuroIntervention 8(3):306–315

    Article  PubMed  Google Scholar 

  12. Hamm CW, Bassand J-P, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF et al (2011) ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevatio. Eur Heart J 32(23):2999–3054

    Article  PubMed  Google Scholar 

  13. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33(20):2569–2619

    Article  CAS  PubMed  Google Scholar 

  14. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky AJ (2003) Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 92(4):463–466

    Article  CAS  PubMed  Google Scholar 

  15. Prati F, Cera M, Ramazzotti V, Imola F, Giudice R, Albertucci M (2007) Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention 3(3):365–370

    Article  PubMed  Google Scholar 

  16. Pijls NNHJ, De Bruyne B, Smith L, De Bruyne B, Aarnoudse W, Barbato E, Bartunek J, Bech GJW, Van De, Vosse F (2002) Coronary thermodilution to assess flow reserve validation in humans. Circulation 105(21):2482–2486

    Article  PubMed  Google Scholar 

  17. Kim S, Kim J-S, Shin D-H, Kim B-K, Ko Y-G, Choi D, Cho Y-K, Nam C-W, Hur S-H, Jang Y, Hong M-K (2013) Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography. Am J Cardiol 111(1):1–5

    Article  CAS  PubMed  Google Scholar 

  18. Karjalainen P, Kiviniemi TO, Lehtinen T, Nammas W, Ylitalo A, Saraste A, Mikkelsson J, Pietila M, Biancari F, Airaksinen JKE (2013) Neointimal coverage and vasodilator response to titanium–nitride–oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial. Int J Cardiovasc Imaging 29(8):1693–1703

    Article  PubMed  Google Scholar 

  19. Silber S, Kirtane AJ, Belardi JA, Liu M, Brar S, Rothman M, Windecker S (2014) Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. Eur Heart J 35(29):1949–1956

    Article  CAS  PubMed  Google Scholar 

  20. Guagliumi G, Capodanno D, Ikejima H, Bezerra HG, Sirbu V, Musumeci G, Fiocca L, Lortkipanidze N, Vassileva A, Tahara S, Valsecchi O, Costa MA (2013) Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST. Catheter Cardiovasc Interv 81(3):510–518

    Article  PubMed  Google Scholar 

  21. Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, Dens J, Hagiwara N, Allocco DJ, Dawkins KD (2011) A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [PROMUS element] for the treatment of up to two de novo cor). J Am Coll Cardiol 57(16):1700–1708

    Article  CAS  PubMed  Google Scholar 

  22. Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tüller D, Zbinden R, Seiler C, Mehilli J, Kastrati A et al (2005) Randomized comparison of a titanium–nitride–oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation 111(20):2617–2622

    Article  CAS  PubMed  Google Scholar 

  23. Romppanen H, Nammas W, Kervinen K, Airaksinen JKE, Pietilä M, Rivero-Crespo F, Debelder A, Tedjokusumo P, Mikkelsson J, Ylitalo A, Karjalainen PP (2013) Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial. Ann Med 45(7):488–493

    Article  CAS  PubMed  Google Scholar 

  24. Lehtinen T, Airaksinen KEJ, Ylitalo A, Karjalainen PP (2012) Stent strut coverage of titanium–nitride–oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study. Int J Cardiovasc Imaging 28(8):1859–1866

    Article  PubMed  Google Scholar 

  25. Annala A-P, Lehtinen T, Kiviniemi TO, Ylitalo A, Nammas W, Karjalainen PP (2013) Vascular healing early after titanium–nitride–oxide-coated stent implantation assessed by optical coherence tomography. J Invasive cardiol 25(4):186–189

    PubMed  Google Scholar 

  26. Prati F, Romagnoli E, Valgimigli M, Burzotta F, De Benedictis M, Ramondo A, Mehran R, Stella PR (2014) Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study. Int J Cardiol 176(3):904–909

    Article  PubMed  Google Scholar 

  27. Guagliumi G, Sirbu V, Bezerra H, Biondi-Zoccai G, Fiocca L, Musumeci G, Matiashvili A, Lortkipanidze N, Tahara S, Valsecchi O, Costa M (2010) Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (optical coherence tomography in acute myocardial infarction) study. JACC Cardiovasc Interv 3(6):680–687

    Article  PubMed  Google Scholar 

  28. Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, Meier B, Hess OM (2007) Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 120(2):212–220

    Article  PubMed  Google Scholar 

  29. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM (2005) Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 46(2):231–236

    Article  CAS  PubMed  Google Scholar 

  30. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JMR, van Essen D, de Feyter PJ, Serruys PW (2006) Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27(2):166–170

    Article  PubMed  Google Scholar 

  31. Ascione L, Carlomagno G, Sordelli C, Iengo R, Monda V, Severino S, Merenda R, D’Andrea A, Caso P (2013) Dipyridamole coronary flow reserve stratifies prognosis in acute coronary syndrome patients without left anterior descending disease. Eur Heart J Cardiovasc Imaging 14(9):858–864

    Article  PubMed  Google Scholar 

  32. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, Picano E (2007) Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50(14):1354–1361

    Article  PubMed  Google Scholar 

  33. Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E, Sicari R (2012) Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging 5(11):1079–1085

    Article  PubMed  Google Scholar 

  34. Gould KL, Lipscomb K (1974) Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34(1):48–55

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Authors deeply thank RN Minna Ampio, RN Kristiina Lahtonen and RN Tuija Vasankari for their excellent technical assistance. This study was supported by Scholarship for research within the area of Acute Coronary Syndrome from the Finnish Cardiac Society (T.K.); by grants from the Finnish Foundation for Cardiovascular Research, Helsinki, Finland (T.K. and J.A.); and by Turku University Hospital Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ville Varho.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varho, V., Kiviniemi, T.O., Nammas, W. et al. Early vascular healing after titanium–nitride–oxide-coated stent versus platinum–chromium everolimus-eluting stent implantation in patients with acute coronary syndrome. Int J Cardiovasc Imaging 32, 1031–1039 (2016). https://doi.org/10.1007/s10554-016-0871-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-016-0871-7

Keywords

Navigation